Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 755 | 2,157 | 3,865 | 3,079 | 2,882 |
| Gross Profit | 755 | 2,157 | 3,865 | 3,079 | 2,882 |
| Operating Expenses | 17,235 | 16,521 | 15,318 | 11,390 | 11,788 |
| Operating Income | -16,480 | -14,364 | -11,453 | -8,311 | -8,906 |
| Interest Expense | 0 | 69 | 61 | 68 | 0 |
| Other Income | 8,382 | -51,102 | -5,009 | -9,075 | 1,486 |
| Pre-tax Income | -8,098 | -65,535 | -16,523 | -17,454 | -7,420 |
| Net Income Continuous | -8,098 | -65,535 | -16,523 | -17,454 | -7,420 |
| Net Income | $-8,098 | $-65,535 | $-16,523 | $-17,454 | $-7,420 |
| EPS Basic Total Ops | -0.08 | -0.75 | -0.19 | -0.25 | -0.12 |
| EPS Basic Continuous Ops | -0.08 | -0.75 | -0.19 | -0.25 | -0.12 |
| EPS Diluted Total Ops | -0.14 | -0.75 | -0.19 | -0.25 | -0.12 |
| EPS Diluted Continuous Ops | -0.07 | -0.75 | -0.19 | -0.25 | -0.12 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.75 | -0.14 | -0.12 | -0.12 |
| EBITDA(a) | $-16,466 | $-14,351 | $-11,440 | $-8,298 | $-8,892 |